Tuesday, 4 April 2017

Teva: Starting to Pierce the Gloom

Regulatory approval for Teva Pharmaceutical Industries’ new treatment for Huntington’s disease offers some much-needed good news.

from WSJ.com: Markets http://ift.tt/2oFhAuX
via https://ifttt.com/ IFTTT
Posted by at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)